HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
95.89
+0.74 (0.78%)
Oct 29, 2025, 10:40 AM EDT - Market open
HealthEquity Employees
HealthEquity had 3,120 employees as of January 31, 2025. The number of employees decreased by 30 or -0.95% compared to the previous year.
Employees
3,120
Change (1Y)
-30
Growth (1Y)
-0.95%
Revenue / Employee
$406,708
Profits / Employee
$46,743
Market Cap
8.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 3,120 | -30 | -0.95% |
| Jan 31, 2024 | 3,150 | -58 | -1.81% |
| Jan 31, 2023 | 3,208 | -507 | -13.65% |
| Jan 31, 2022 | 3,715 | 676 | 22.24% |
| Jan 31, 2021 | 3,039 | 108 | 3.68% |
| Jan 31, 2020 | 2,931 | 1,790 | 156.88% |
| Jan 31, 2019 | 1,141 | 114 | 11.10% |
| Jan 31, 2018 | 1,027 | 152 | 17.37% |
| Jan 31, 2017 | 875 | 239 | 37.58% |
| Jan 31, 2016 | 636 | 181 | 39.78% |
| Jan 31, 2015 | 455 | 74 | 19.42% |
| Apr 30, 2014 | 381 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HQY News
- 6 days ago - These low-risk stocks could be a profitable answer to this volatile earnings season - Market Watch
- 15 days ago - HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms - GlobeNewsWire
- 4 weeks ago - HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation - GlobeNewsWire
- 7 weeks ago - HealthEquity: Swing Trading Stock With A Beat And Raise - Seeking Alpha
- 2 months ago - HealthEquity, Inc. (HQY) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - HealthEquity Stock Climbs After Q2 Earnings Report: Here's Why - Benzinga
- 2 months ago - HealthEquity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 2 months ago - HealthEquity: Scale Platform With Asset‑Linked Revenues And Thick Incremental Margins - Seeking Alpha